What is Eagle Tissue?
Eagle Tissue operates as a specialized national converter of retail and industrial wrapping tissue, maintaining a robust presence in the packaging supply chain for over twenty years. The firm distinguishes itself through a commitment to environmental stewardship, offering a diverse product portfolio that includes #1 White Tissue composed of 75% post-consumer content and #2 Packing Tissue manufactured from 100% recycled materials. By catering to both retail packaging distributors and national retail chains, Eagle Tissue has established a reliable reputation for high-quality, sustainable paper solutions. Their business model integrates custom printing capabilities with large-scale distribution, ensuring they remain a critical partner for businesses prioritizing both functionality and eco-conscious branding.
How much funding has Eagle Tissue raised?
Eagle Tissue has raised a total of $111K across 1 funding round:
Debt
$111K
Debt (2021): $111K with participation from PPP
Key Investors in Eagle Tissue
PPP
Public-Private Partnership
What's next for Eagle Tissue?
Following this late-stage financing, Eagle Tissue is expected to prioritize the scaling of its production infrastructure and the expansion of its sustainable product lines. The strategic allocation of this capital will likely focus on enhancing supply chain efficiencies and deepening relationships with national retail partners. As the packaging industry continues to shift toward circular economy principles, Eagle Tissue is poised to capitalize on the growing demand for recycled materials. Future growth initiatives will likely involve optimizing their custom printing services to meet the bespoke needs of high-volume retail clients, thereby solidifying their role as a leader in the sustainable packaging market.
See full Eagle Tissue company page
